| Condition and SOPs under review | Gazettal date | Closing date for submissions |
|---|---|---|
|
Rheumatoid arthritis Nos. 50 and 51 of 2017 review of a decision by the Repatriation Medical Authority not to amend Statements of Principles |
GN No. C2017G01246 of 20 November 2017 | 9 March 2018 |
|
“Chemically acquired brain injury caused by mefloquine, tafenoquine or primaquine”. review of a decision by the Repatriation Medical Authority not to determine Statements of Principles |
GN No. C2017G011856 of 06 November 2017 | 9 February 2018 |